DSIP
Delta Sleep-Inducing Peptide
A nine-amino-acid peptide named for the one thing it may not reliably do. The community runs it as a pre-sleep shot for deeper, more restorative nights — but its real human track record points more toward stress and pain than sleep, and that gap between the name and the evidence is the whole story here.
What it is
People run it for sleep quality — not falling asleep faster so much as sleeping deeper and waking more recovered. The most-repeated routine is a small dose before bed to push slow-wave and REM sleep. Worth knowing up front: the human studies behind it are decades old and the sleep effect itself is inconsistent, so this is one of the more faith-based protocols on the site.
Its name is also its biggest caveat. It was isolated in the 1970s and labeled a “sleep-inducing” peptide, but the human work that followed found its more replicated effects were on pain tolerance and on stress/withdrawal states — not sleep per se. The community has largely adopted it as a sleep peptide anyway, which makes it a clean example of a compound whose reputation ran ahead of its evidence. The honest read: people report calmer, deeper sleep, but the literature can't firmly confirm that's what it does.
Mechanism
Genuinely uncertain — and that's the honest answer. DSIP is a small endogenous peptide found in the brain, and despite fifty years it has no well-established receptor or mechanism. Proposed actions include modulating slow-wave sleep, blunting the stress/cortisol axis, and altering pain perception, but none is settled. Anyone claiming a precise mechanism is overstating what's known.
Step 1 · the name
Named for one thing: sleep.
Isolated in the 1970s and labeled the “delta sleep-inducing peptide,” it’s run as a small shot before bed — not to fall asleep faster so much as to sleep deeper and wake more recovered.
Step 2 · the dose
A small dose, about half an hour before bed.
Reconstituted and pinned subcutaneously, low — around 100 mcg. That part of the protocol is settled. What it does next is where the honesty starts.
Step 3 · the honest part
Fifty years on, no one knows how it works.
DSIP is a small peptide the brain makes — but it has no well-established receptor and no settled mechanism. Anyone claiming a precise pathway is overstating what’s actually known.
Step 4 · the candidates
Three proposed actions — none confirmed.
It’s been proposed to deepen slow-wave sleep, to blunt the stress and cortisol axis, and to raise pain tolerance. All three are candidates. None is established.
Step 5 · what held up
The firmer findings aren’t about sleep.
Tellingly, the human results that replicated best were on pain and on stress and withdrawal states — not sleep itself. The sleep effect, the thing it’s named for, is the least supported of the three.
Step 6 · the gap
The reputation ran ahead of the evidence.
The community adopted it as a sleep peptide anyway. It’s a clean example of a name outrunning its data — old, small, European studies, never followed up with modern trials.
The result
Plausible — and unproven.
People do report calmer, deeper sleep. The honest read is to treat that as plausible-but-unproven: light, casual use over a thin, dated evidence base. Absence of reported harm isn’t the same as proven safety.
Real human studies exist — but old (1977–1992), small, and European, never replicated in modern trials. The firmer findings are on pain and stress, not sleep. Treat the sleep benefit as plausible-but-unproven.
Standard dose
| Standard dose | ~100 mcg before bed; 100–300 mcg is the common range (proposed — pending dosing review)community |
|---|---|
| Timing | ~30 minutes before sleep — the single most-repeated instructioncommunity |
| Frequency | Nightly during a cycle; most people run it in blocks (a few weeks) rather than indefinitelycommunity |
| Route | SubQ; reconstituted and refrigeratedcommunity |
Reconstitution calculator
U-100 · 100u = 1 mL= 200 units
Set the vial size and water to match your product — amounts vary by supplier. This is unit-conversion math, not medical advice or a dosing recommendation.
Pushing higher— going beyond the standard dosecommunity
Side effects & cautions
Generally described as mild and well-tolerated, which is one of the few consistent threads. The most-mentioned issue is morning grogginess or feeling tired if dosed too high or too late, plus occasional headache. There's no signal of anything serious in the community reports — but that reflects light, casual use and old, small studies, not a thorough modern safety record. Absence of reported harm isn't the same as proven safety.
Stacking
Treated as a sleep/recovery layer rather than a standalone. The most common pairings are with melatonin and magnesium as conventional sleep support, and within peptide circles it's frequently mentioned alongside Epitalon (run for longevity/sleep) and Selank (for daytime calm). None of these combinations rests on trial evidence — they're community routines built around the shared goal of better sleep and lower stress.
Evidence & sources
Real human studies exist — but they're old (1977–1992), small, European, and never followed up with modern trials. Tellingly, the more replicated human findings are on pain and stress/withdrawal, not sleep, so the popular framing as a sleep peptide is only loosely supported. Treat the sleep benefit as plausible-but-unproven.
- Schneider-Helmert D (1981)Human studyDSIP in the treatment of insomniaEuropean human study — early sleep dataPMID 6895513 ↗
- DSIP double-blind controlled study (1992)Human studyDouble-blind evaluation of DSIPControlled human trialPMID 1299794 ↗
- Larbig W et al. (1984)Human studyDSIP in chronic pain — pilotHuman pilot — pain, not sleepPMID 6548970 ↗
- Dick P et al. (1984)Human studyDSIP in withdrawal states (n=107)Human study — stress/withdrawal signalPMID 6548969 ↗
- Kovalzon VM, Strekalova TV (2006)ReviewDelta sleep-inducing peptide (DSIP): a still unresolved riddleReview — summarizes the contested evidencePMID 16539679 ↗